News 2018-04-14
Porton Attend Asia Pharma R&D Leaders’ Summit 2018
Visit us at Booth No.6.
Porton Pharma Solutions Ltd. (former name: Porton Fine Chemicals Ltd) founded in 2005, is a top-tier CDMO, providing services to the global pharmaceutical industry with intergraded research, development and manufacturing of custom drug intermediates and APIs.
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
